Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-06-06

Clinical Trial Update: GGT and Uric Acid to Predict Gestational Diabetes Mellitus

View source ↗

Summary

The clinical trial investigating whether gamma-glutamyltransferase (GGT) and uric acid can predict gestational diabetes mellitus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mount Carmel Health System | Conditions: Gestational Diabetes | Status: WITHDRAWN